Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease

被引:2
|
作者
Keleman, Audrey A. [1 ]
Nicosia, Jessica y [2 ]
Bollinger, Rebecca M. [1 ]
Wisch, Julie K. [2 ]
Hassenstab, Jason [2 ,3 ]
Morris, John C. [2 ,5 ]
Ances, Beau M. [2 ,4 ,5 ]
Balota, David A. [3 ]
Stark, Susan L. [1 ,2 ]
机构
[1] Washington Univ St Louis, Program Occupat Therapy, St Louis, MO USA
[2] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[3] Washington Univ St Louis, Dept Psychol, St Louis, MO USA
[4] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[5] Washington Univ St Louis, Hope Ctr Neurol Disorders, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognition; falls; functional mobility; DWELLING OLDER-PEOPLE; RISK-FACTORS; DATA SET; GAIT SPEED; PERFORMANCE; VALIDATION; VERSION; HEALTH; TAU; PREDICTOR;
D O I
10.3233/ADR-230002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individuals with Alzheimer's disease (AD) are more than twice as likely to incur a serious fall as the general population of older adults. Although AD is commonly associated with cognitive changes, impairments in other clinical measures such as strength or functional mobility (i.e., gait and balance) may precede symptomatic cognitive impairment in preclinical AD and lead to increased fall risk. Objective: To examine mechanisms (i.e., functional mobility, cognition, AD biomarkers) associated with increased falls in cognitively normal older adults. Methods: This 1-year study was part of an ongoing longitudinal cohort study. We examined the relationships among falls, clinical measures of functional mobility and cognition, and neuroimaging AD biomarkers in cognitively normal older adults. We also investigated which domain(s) best predicted fall propensity and severity through multiple regression models. Results: A total of 182 older adults were included (mean age 75 years, 53% female). A total of 227 falls were reported over the year; falls per person ranged from 0-16 with a median of 1. Measures of functional mobility were the best predictors of fall propensity and severity. Cognition and AD biomarkers were associated with each other but not with the fall outcome measures. Conclusion: These results suggest that, although subtle changes in cognition may be more closely associated with AD neuropathology, functional mobility indicators better predict falls in cognitively normal older adults. This study adds to our understanding of the mechanisms underlying falls in older adults and could lead to the development of targeted fall prevention strategies.
引用
收藏
页码:739 / 750
页数:12
相关论文
共 50 条
  • [41] Cognitive impairment in preclinical Alzheimer's disease:: A meta-analysis
    Bäckman, L
    Jones, S
    Berger, AK
    Laukka, EJ
    Small, BJ
    NEUROPSYCHOLOGY, 2005, 19 (04) : 520 - 531
  • [42] Anthocyanin as a therapeutic in Alzheimer's disease: A systematic review of preclinical evidences
    Suresh, Swathi
    Begum, Rukaiah Fatma
    Singh, Ankul S.
    Chitra, V
    AGEING RESEARCH REVIEWS, 2022, 76
  • [43] Phenomenological Characterization of Memory Complaints in Preclinical and Prodromal Alzheimer's Disease
    Buckley, Rachel F.
    Ellis, Kathryn A.
    Ames, David
    Rowe, Christopher C.
    Lautenschlager, Nicola T.
    Maruff, Paul
    Villemagne, Victor L.
    Macaulay, S. Lance
    Szoeke, Cassandra
    Martins, Ralph N.
    Masters, Colin L.
    Savage, Greg
    Rainey-Smith, Stephanie R.
    Rembach, Alan
    Saling, Michael M.
    NEUROPSYCHOLOGY, 2015, 29 (04) : 571 - 581
  • [44] Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease
    Edmonds, Emily C.
    Delano-Wood, Lisa
    Galasko, Douglas R.
    Salmon, David P.
    Bondi, Mark W.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 231 - 242
  • [45] Prediction of Preclinical Alzheimer's Disease: Longitudinal Rates of Change in Cognition
    Riley, Kathryn P.
    Jicha, Gregory A.
    Davis, Daron
    Abner, Erin L.
    Cooper, Gregory E.
    Stiles, Nancy
    Smith, Charles D.
    Kryscio, Richard J.
    Nelson, Peter T.
    Van Eldik, Linda J.
    Schmitt, Frederick A.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (04) : 707 - 717
  • [46] Prevention Strategies Targeting Different Preclinical Stages of Alzheimer's Disease
    Zhou, Bin
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (06) : 504 - 506
  • [47] An olfactory 'stress test' may detect preclinical Alzheimer's disease
    Schofield, Peter W.
    Ebrahimi, Houman
    Jones, Alison L.
    Bateman, Grant A.
    Murray, Sonya R.
    BMC NEUROLOGY, 2012, 12
  • [48] Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease
    Bagan, Andrea
    Rodriguez-Arevalo, Sergio
    Taboada-Jara, Teresa
    Grinan-Ferre, Christian
    Pallas, Merce
    Brocos-Mosquera, Iria
    Callado, Luis F.
    Morales-Garcia, Jose A.
    Perez, Belen
    Diaz, Caridad
    Fernandez-Godino, Rosario
    Genilloud, Olga
    Beljkas, Milan
    Oljacic, Slavica
    Nikolic, Katarina
    Escolano, Carmen
    PHARMACEUTICS, 2023, 15 (10)
  • [49] Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
    Arnáiz, E
    Almkvist, O
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 : 34 - 41
  • [50] Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
    Gao, Yu
    Tan, Lin
    Yu, Jin-Tai
    Tan, Lan
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (03) : 283 - 300